Détail de l'auteur
Auteur D. NEWCOMBE |
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat à votre sélection Affiner la recherche
NouveautéJ. SHERIDAN ; P. ADAMS ; C. BULLEN ; D. NEWCOMBE | 2018
Dans Drugs: Education, Prevention and Policy (Vol.25, n°2, April 2018) Article : PériodiqueAims: The role of health professionals in the provision of harm reduction services is well established in some countries, but not all. We describe a two week course in harm reduction for undergraduate health professionals from a range of countri[...]R. HUMENIUK ; R. ALI ; T. F. BABOR ; M. L. SOUZA FORMIGONI ; R. B. DE LACERDA ; W. LING ; B. McREE ; D. NEWCOMBE ; H. PAL ; V. POZNYAK ; S. SIMON ; J. VENDETTI | 2012
Dans Addiction (Vol.107, n°5, May 2012) Article : PériodiqueAIMS: This study evaluated the effectiveness of a brief intervention (BI) for illicit drugs (cannabis, cocaine, amphetamine-type stimulants and opioids) linked to the World Health Organization (WHO) Alcohol, Smoking and Substance Involvement Scr[...]C. WILKINS ; J. SHERIDAN ; P. ADAMS ; B. RUSSELL ; S. RAM ; D. NEWCOMBE | 2013
Dans Journal of Psychopharmacology (Vol.27, n°7, July 2013) Article : PériodiqueThe New Zealand government has proposed a new psychoactive substances regime, which will place the onus onto manufacturers to prove that their products pose a low risk of harm, prior to receiving approval which allows the products to be legally [...]N. LINTZERIS ; L. A. MONDS ; C. RIVAS ; S. LEUNG ; A. DUNLOP ; D. NEWCOMBE ; C. WALTERS ; S. GALEA ; N. WHITE ; M. MONTEBELLO ; A. DEMIRKOL ; N. SWANSON ; R. ALI | 2018
Dans Journal of Addiction Medicine (Vol.12, n°3, May-June 2018) Article : PériodiqueINTRODUCTION AND AIMS: Transfer from methadone to buprenorphine is problematic for many opioid-dependent patients, with limited documented evidence or practical clinical guidance, particularly for the range of methadone doses routinely prescribe[...]